Fig. 5From: Construction of a novel signature based on immune-related lncRNA to identify high and low risk pancreatic adenocarcinoma patientsThe independent prognostic analysis of prognostic risk model. (A-B) The univariate (A) and multivariate (B) regression analysis of prognostic risk model and clinical characteristics. (C-E) The 1-, 2-, and 3-year ROC of the prognostic risk model and clinical characteristicsBack to article page